Literature DB >> 1323495

Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis.

M H Chang1, H H Huang, E S Huang, C L Kao, H Y Hsu, C Y Lee.   

Abstract

Neonatal hepatitis is closely related to human cytomegalovirus infection in Taiwan, a conclusion based on serological and urine culture studies. To obtain more direct evidence further relating cytomegalovirus to the pathogenesis of neonatal hepatitis, the cytomegalovirus genome was studied in the liver tissues of 50 infants with neonatal hepatitis using the polymerase chain reaction (PCR). Liver tissues from 26 infants with biliary atresia and another 30 infants and children with diagnoses other than neonatal hepatitis, cholestasis, or hepatitis were also studied for comparison. Sequences from the immediate early gene 1 and 2 regions were used as primers. The liver tissues from 23 (46%) of the 50 infants with neonatal hepatitis were positive for cytomegalovirus genome, whereas those of 2 of the 26 infants with biliary atresia and none of the liver tissues from 30 infants and children without neonatal hepatitis were positive for cytomegalovirus genome, by PCR. The results of PCR correlated well with that of serology and urine culture. This study provides further evidence of cytomegalovirus in the pathogenesis of neonatal hepatitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323495     DOI: 10.1016/0016-5085(92)90038-z

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

2.  Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences.

Authors:  Hiroshi Nakase; Hans Herfarth
Journal:  Inflamm Intest Dis       Date:  2016-01-23

3.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

4.  Cytomegalovirus excretion in pregnant and nonpregnant women.

Authors:  C Y Shen; S F Chang; M S Yen; H T Ng; E S Huang; C W Wu
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

Review 5.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

6.  Incidence of hepatotropic viruses in biliary atresia.

Authors:  Stefan Rauschenfels; Miriam Krassmann; Ahmed N Al-Masri; Willem Verhagen; Johannes Leonhardt; Joachim F Kuebler; Claus Petersen
Journal:  Eur J Pediatr       Date:  2008-06-17       Impact factor: 3.183

7.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Cytomegalovirus frequency in neonatal intrahepatic cholestasis determined by serology, histology, immunohistochemistry and PCR.

Authors:  Maria Angela Bellomo-Brandao; Paula D Andrade; Sandra C B Costa; Cecilia A F Escanhoela; Jose Vassallo; Gilda Porta; Adriana M A De Tommaso; Gabriel Hessel
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

Review 9.  Systematic review: cytomegalovirus infection in inflammatory bowel disease.

Authors:  Hiroshi Nakase; Kayoko Matsumura; Takuya Yoshino; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 6.772

10.  High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis.

Authors:  Adriana M A De Tommaso; Paula D Andrade; Sandra C B Costa; Cecília A F Escanhoela; Gabriel Hessel
Journal:  BMC Infect Dis       Date:  2005-12-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.